Skip to main navigation Skip to search Skip to main content

A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force

  • John F.P. Bridges*
  • , Esther W. de Bekker-Grob
  • , Brett Hauber
  • , Sebastian Heidenreich
  • , Ellen Janssen
  • , Alice Bast
  • , Janel Hanmer
  • , Andriy Danyliv
  • , Eric Low
  • , Jacoline C. Bouvy
  • , Deborah A. Marshall
  • *Corresponding author for this work
  • Ohio State University
  • Pfizer
  • Evidera, United Kingdom
  • Johnson & Johnson
  • Beyond Celiac
  • University of Pittsburgh
  • Novartis
  • Eric Low Consulting
  • NICE - National Institute for Health and Care Excellence (London)
  • University of Calgary

Research output: Contribution to journalArticleAcademicpeer-review

75 Citations (Scopus)

Abstract

Many qualitative and quantitative methods are readily available to study patient preferences in health. These methods are now being used to inform a wide variety of decisions, and there is a growing body of evidence showing studies of patient preferences can be used for decision making in a wide variety of contexts. This ISPOR Task Force report synthesizes current good practices for increasing the usefulness and impact of patient-preference studies in decision making. We provide the ISPOR Roadmap for Patient Preferences in Decision Making that invites patient-preference researchers to work with decision makers, patients and patient groups, and other stakeholders to ensure that studies are useful and impactful. The ISPOR Roadmap consists of 5 key elements: (1) context, (2) purpose, (3) population, (4) method, and (5) impact. In this report, we define these 5 elements and provide good practices on how patient-preference researchers and others can actively contribute to increasing the usefulness and impact of patient-preference studies in decision making. We also present a set of key questions that can support researchers and other stakeholders (eg, funders, reviewers, readers) to assess efforts that promote the ongoing impact (both intended and unintended) of a particular preference study and additional studies in the future.

Original languageEnglish
Pages (from-to)153-162
Number of pages10
JournalValue in Health
Volume26
Issue number2
DOIs
Publication statusPublished - Feb 2023

Bibliographical note

Publisher Copyright: © 2023 International Society for Pharmacoeconomics and Outcomes Research, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force'. Together they form a unique fingerprint.

Cite this